Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer.

Volume: 105, Issue: 6
Published: Aug 28, 2019
Abstract
Introduction:Immunotherapy has shown efficacy in the treatment of different malignancies. Nivolumab, an immune checkpoint inhibitor directed against programmed death-1, has been approved for...
Paper Details
Title
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer.
Published Date
Aug 28, 2019
Journal
Volume
105
Issue
6
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.